Here comes the preview trailer for China-Japan Forum!
Elaborately filmed in Chengdu and Kobe
All efforts
Just for the unveiling moment!
November 10th, meeting in Chengdu, be there or be square!
On November 10 th, the "2019 China-Japan Advanced Medical and New Drug R & D Summit Forum & Achievements Transformation Conference" will be held in Chengdu.
More than one hundred items of advanced medical and new drug research and development achievements from Japan will be strikingly pooled for the all-around and multiple-channel way of display and transformation.
The conference will make free exhibition boards for each registered participant for achievement display and communication, and publicize them on the conference website. You are welcome to provide projects and achievements that need to be displayed and communicated.
Please follow our WeChat public account "China-Japan Advanced Medical Achievement Transformation Platform" for more achievements details.
(Scan the QR code above for more achievements information)
More than 200 leading Chinese and Japanese pharmaceutical companies are gathering in Chengdu to select projects, launching the "Through Train of China-Japan Biomedical Achievements Transformation ".
More than 200 leading pharmaceutical companies from China and Japan, including Otsuka Pharmaceutical Co., Takeda Pharmaceutical Co., Ltd., Fuji Film Co., Ltd. (FUJIFILM), Shanghai Pharmaceuticals Holding Co., Ltd., China National Pharmaceutical Group Corporation, Guangzhou Pharmaceutical Holdings Limited etc., will attend the conference and jointly launch the "Through Train of China-Japan Biomedical Achievements Transformation ".
More than 60 large domestic and foreign investment institutions are exploring new model of cooperation and strengthening the deep integration of "projects supermarket" and capital.
More than 60 large investment institutions, such as China Securities Co., Ltd., Guangfa Securities Co., Ltd., Shenzhen GTJA Investment Group, Chengdu Industry Investment Co., Ltd., China International Capital Co., Ltd., Shenzhen Green Pine Capital Partners, IDG Capital Investment Consultant (Beijing) Co., Ltd., PICC Investment Holding Co., Ltd., Bank of America Merrill Lynch (Asia-Pacific) Co., Ltd., Ping An Property and Casualty Insurance Co., Ltd. etc., will attend the conference, exploring new mechanisms and models to transfer and transform the medical scientific and technological achievements from the "projects supermarket".
The docking of multiple pharmaceutical industrial parks accelerates the targeted docking and effective transformation between the most advanced scientific and technological medical achievements and industry resources.
Pharmaceutical industrial parks include Tianfu Central Business District, Chengdu Frontier Medical Center, Chengdu Tianfu International Bio-city, Wenjiang Industrial Park, Wuhou District-Dahecang Health Industrial Park, and Pengzhou Tianfu Traditional Chinese Medicine City are docked, where enterprises on the Through Train will enjoy the favorable policies of these industrial parks, quickly link to the most advanced and cutting-edge medical resources of China and Japan, and accelerate the targeted docking and effective transformation between the advanced medical scientific and technological achievements and industrial resources.
Dozens of top experts in the field of biomedical R & D in China and Japan, keynote speeches, media exclusive interviews ... on-spot face-to-face dialogues.
The director of Japan Kobe Translational Research Center for Medical Innovation (TRI), the leaders from Japan National Food and Drug Administration, China National Drug Administration and dozens of top experts in the field of biomedical R & D in China and Japan will come to the meeting with wonderful keynote speeches sharing on cutting-edge trend of medical and pharmaceutical development. A number of well-known media will organize interview teams to conduct face-to-face interviews with experts.
